Covaxin deal: Bharat Biotech denies allegations of irregularities, says no advance payment received from Brazil

Brazilian federal prosecutors have opened an investigation into the Covaxin deal, citing comparatively high prices, quick talks and pending regulatory approvals as red flags for the contract signed in February.